Conduit Pharmaceuticals Correlations

CDT Stock

0.12 0.01 7.69%

The current 90-days correlation between Conduit Pharmaceuticals and Dominari Holdings is -0.05 (i.e., Good diversification). The correlation of Conduit Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Conduit Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Conduit Pharmaceuticals and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Conduit Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.

Moving against Conduit Stock

0.68	A	Agilent Technologies Fiscal Year End 18th of November 2024	Pair Corr
0.68	DMAC	DiaMedica Therapeutics	Pair Corr
0.6	VCYT	Veracyte	Pair Corr
0.49	EQ	Equillium	Pair Corr
0.42	DNLI	Denali Therapeutics	Pair Corr
0.4	VERA	Vera Therapeutics	Pair Corr
0.78	VRNA	Verona Pharma PLC	Pair Corr
0.71	DSGN	Design Therapeutics	Pair Corr
0.47	VRDN	Viridian Therapeutics	Pair Corr
0.46	VKTX	Viking Therapeutics	Pair Corr
0.38	VRAX	Virax Biolabs Group	Pair Corr
0.76	VTRS	Viatris	Pair Corr
0.4	VXRT	Vaxart Inc	Pair Corr

Related Correlations Analysis

	A	DMAC	VALN	DNLI	DOMH	VCEL	VCNX	VCYT	VERV	DRMA
A		0.75	-0.23	0.62	-0.39	-0.05	-0.67	0.76	-0.2	-0.43	A
DMAC	0.75		-0.4	0.84	-0.05	-0.17	-0.46	0.8	-0.17	-0.58	DMAC
VALN	-0.23	-0.4		-0.68	-0.46	0.49	0.4	-0.3	0.21	0.14	VALN
DNLI	0.62	0.84	-0.68		0.29	-0.29	-0.46	0.74	-0.24	-0.53	DNLI
DOMH	-0.39	-0.05	-0.46	0.29		-0.25	0.29	-0.26	0.16	-0.11	DOMH
VCEL	-0.05	-0.17	0.49	-0.29	-0.25		0.53	-0.28	0.71	0.0	VCEL
VCNX	-0.67	-0.46	0.4	-0.46	0.29	0.53		-0.69	0.62	0.18	VCNX
VCYT	0.76	0.8	-0.3	0.74	-0.26	-0.28	-0.69		-0.54	-0.51	VCYT
VERV	-0.2	-0.17	0.21	-0.24	0.16	0.71	0.62	-0.54		0.06	VERV
DRMA	-0.43	-0.58	0.14	-0.53	-0.11	0.0	0.18	-0.51	0.06		DRMA
	A	DMAC	VALN	DNLI	DOMH	VCEL	VCNX	VCYT	VERV	DRMA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DNLI	+ 0.84	DMAC
VCYT	+ 0.8	DMAC
VCYT	+ 0.76	A
DMAC	+ 0.75	A
VCYT	+ 0.74	DNLI
VERV	+ 0.71	VCEL

High negative correlations

VCYT	- 0.69	VCNX
DNLI	- 0.68	VALN
VCNX	- 0.67	A
DRMA	- 0.58	DMAC
VERV	- 0.54	VCYT
DRMA	- 0.53	DNLI

Risk-Adjusted Indicators

There is a big difference between Conduit Stock performing well and Conduit Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Conduit Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
A	1.10	0.08	0.06	0.18	1.17	(1.12)	2.84	(2.08)	6.98
DMAC	2.94	0.59	0.13	(1.24)	2.95	(3.38)	6.67	(5.08)	17.58
VALN	2.17	(0.32)	0.00	(0.22)	0.00	0.00	3.61	(4.08)	22.28
DNLI	2.27	0.22	0.10	0.25	2.39	(2.40)	5.71	(4.44)	15.90
DOMH	2.38	(0.08)	(0.03)	0.01	3.23	(2.63)	5.63	(5.71)	23.01
VCEL	2.08	(0.30)	0.00	(0.09)	0.00	0.00	4.58	(3.70)	14.65
VCNX	5.33	(0.51)	0.00	1.21	0.00	0.00	9.94	(11.82)	64.11
VCYT	2.77	0.47	0.24	0.31	2.18	(3.38)	8.79	(4.18)	28.15
VERV	4.10	(0.11)	0.01	0.06	4.85	(4.25)	9.30	(8.27)	20.10
DRMA	9.59	1.19	0.05	(0.11)	8.56	(15.00)	29.84	(15.42)	127.61

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC